Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma

NCT05385926 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
34
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences